Wirth is the CEO of Amida Care. Crowley is the director of the O’Neill Institute’s Center for HIV and Infectious Disease Policy at Georgetown Law. In June, a clinical trial showed that a twice-yearly ...

Medicaid provides health coverage for disabled and low-income populations, and the ACA expansion gives states the option to extend coverage to adults with up to 138% of the federal poverty line.

Pre-exposure prophylaxis (PrEP) is a medication regimen that is used to protect at-risk populations from HIV infection. The FDA approved the drug TRUVADA ...

A data analysis found a 22% reduction in HIV pre-exposure prophylaxis (PrEP) prescriptions and a 25% reduction in new PrEP users in the United States after COVID-19 was declared a national emergency.

Medicaid expansion under the Affordable Care Act (ACA) significantly increased the number of people at risk of HIV diagnosis ...

Earlier this year, we wrote about PrEP (pre-exposure prophylaxis), a drug that prevents people from getting the HIV virus -- but which, after a decade, still needs to make more headway in the gay ...

The HIV epidemic remains a critical public health priority in the United States. The Ending the HIV Epidemic (EHE) initiative seeks to reduce HIV diagnoses by 75% by 2025 and by 90% by 2030. Certain ...

Please provide your email address to receive an email when new articles are posted on . The proportion of transgender patients prescribed gender-affirming hormone therapy also rose. Clinicians can use ...

Sustaining the achievements of the past two decades of global HIV programs and reaching the goal of ending HIV/AIDS as a public health threat by 2030 depend on dramatically reducing new infections.